ANTIGENICS INC /DE/
10-Q, EX-27, 2000-11-13
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: ANTIGENICS INC /DE/, 10-Q, 2000-11-13
Next: ANTIGENICS INC /DE/, 424B3, 2000-11-13



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
SEPTEMBER 30, 2000 UNAUDITED FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                     101,553,087
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                           102,743,013
<PP&E>                                      11,122,908
<DEPRECIATION>                               2,499,227
<TOTAL-ASSETS>                             112,098,188
<CURRENT-LIABILITIES>                        3,954,180
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       248,075
<OTHER-SE>                                 106,432,767
<TOTAL-LIABILITY-AND-EQUITY>               112,098,188
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                            18,184,158
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             296,345
<INCOME-PRETAX>                           (13,959,971)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                       (13,959,971)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (13,959,971)
<EPS-BASIC>                                     (0.58)
<EPS-DILUTED>                                   (0.58)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission